Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.76K Buy
+100
New +$2.21K ﹤0.01% 4574
2026
Q1
Sell
-5,900
Closed -$74.6K 4918
2025
Q4
$74.6K Buy
5,900
+500
+9% +$7.38K ﹤0.01% 3965
2025
Q3
$83.1K Sell
5,400
-33,600
-86% -$542K ﹤0.01% 3797
2025
Q2
$613K Buy
+39,000
New +$591K ﹤0.01% 2474
2024
Q4
Sell
-6,300
Closed -$176K 5455
2024
Q3
$176K Buy
+6,300
New +$178K ﹤0.01% 4090
2023
Q4
Sell
-11,000
Closed -$217K 5439
2023
Q3
$217K Buy
+11,000
New +$217K ﹤0.01% 3490

Other funds holding RXO

Walleye Capital's RXO Position: Q2 2026 in Review

Walleye Capital opened a new position in RXO (RXO) in Q2 2026: 12,748 shares worth $352K. The stake represents ﹤0.01% of the portfolio and ranks #3043 among its holdings. This is a return to the name: Walleye Capital previously reported a position in RXO as recently as Q2 2025.

Walleye Capital first reported a position in RXO in Q3 2024 and has held it in 3 quarters since. The position peaked at $2.29M in Q2 2025. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Walleye Capital held 12,748 shares of RXO worth $352K as of Q2 2026.
  • RXO was a new Walleye Capital position in Q2 2026.
  • RXO made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3043 holding.
  • Walleye Capital first reported a position in RXO in Q3 2024 and has held it in 3 quarters since.
  • Walleye Capital's RXO position peaked at $2.29M in Q2 2025.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.